Literature DB >> 1404137

Childhood linear scleroderma: a possible role of thermography for evaluation.

N Birdi1, A Shore, P Rush, R M Laxer, E D Silverman, B Krafchik.   

Abstract

Linear scleroderma is a rare, at times debilitating, disease with an unpredictable course. Currently, there is no satisfactory objective method for assessment of disease activity upon which to base therapeutic decisions. We evaluated 11 children with 18 linear scleroderma lesions (mean age 11.7 years, mean duration of disease 5.1 years) for disease severity and the presence of immunologic abnormalities, and attempted to correlate these results with thermography. Positive thermography was defined as warmer than surrounding skin or opposite limb by 0.5 degrees C. Six patients were thermography positive. Mean age, sex, disease duration and the presence of hypergammaglobulinemia and autoantibodies were similar in thermography positive and thermography negative patients. Six of 18 linear scleroderma lesions were thermography positive. All 3 new or expanding lesions were thermography positive. All 3 lesions that were resolving clinically were thermography negative. Three of 12 lesions that were clinically unchanged over a 6-month period were also thermography positive. In summary, thermography is a noninvasive test that appears to demonstrate active lesions in linear scleroderma. It is not influenced by previous soft tissue damage induced by linear scleroderma and may enable better monitoring of the effectiveness of proposed therapies.

Entities:  

Mesh:

Year:  1992        PMID: 1404137

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Thermography for evaluation of localized scleroderma treated with methotrexate and corticosteroid.

Authors:  Yasuyo Kashiwagi; Hisashi Kawashima; Kazushi Agata; Mai Akaba; Akane Hirose; Soken Go; Shigeo Nishimata; Yoshihito Mitsuhashi; Ryoji Tsuboi
Journal:  Indian J Pediatr       Date:  2013-07-12       Impact factor: 1.967

2.  Parry-romberg syndrome: a rare entity.

Authors:  Hiren Patel; Chintan Thakkar; Kajal Patel
Journal:  J Maxillofac Oral Surg       Date:  2010-11-27

3.  The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

Review 4.  [Morphea or localized scleroderma and extragenital lichen sclerosus].

Authors:  P Moinzadeh; A Kreuter; T Krieg; N Hunzelmann
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

5.  The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.

Authors:  Christina E Kelsey; Kathryn S Torok
Journal:  J Am Acad Dermatol       Date:  2013-04-04       Impact factor: 11.527

Review 6.  Pediatric scleroderma: systemic or localized forms.

Authors:  Kathryn S Torok
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.